Michael L. Curtin
- Co-authors
- Keith B. GlaserWilliam H. OkamuraSteven K. DavidsenPatrick A. MarcotteMichael R. MichaelidesRobin R. FreyLori J. PeaseRobert B. Garland
- Topics
- Peptidase Inhibition and Analysis (10 papers)Histone Deacetylase Inhibitors Research (10 papers)Protein Degradation and Inhibitors (9 papers)
- Journals
- New England Journal of MedicineJournal of the American Chemical SocietyBiochemical and Biophysical Research Communications
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Michael L. Curtin
40 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 640
- Organic Chemistry 633
- Oncology 286
- Cancer Research 128
- Pharmacology 64
Countries citing papers authored by Michael L. Curtin
This map shows the geographic impact of Michael L. Curtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Curtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Curtin more than expected).
Fields of papers citing papers by Michael L. Curtin
This network shows the impact of papers produced by Michael L. Curtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Curtin. The network helps show where Michael L. Curtin may publish in the future.
Co-authorship network of co-authors of Michael L. Curtin
This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Curtin. A scholar is included among the top collaborators of Michael L. Curtin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Curtin. Michael L. Curtin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 12 | |
| 3 | 33 | |
| 4 | 51 | |
| 5 | 37 | |
| 6 | 26 | |
| 7 | 33 | |
| 8 | 58 | |
| 9 | 67 | |
| 10 | 33 | |
| 11 | 12 | |
| 12 | 97 | |
| 13 | 116 | |
| 14 | 43 | |
| 15 | 66 | |
| 16 | 6 | |
| 17 | 26 | |
| 18 | 8 | |
| 19 | 6 | |
| 20 | 25 |
About Michael L. Curtin
Michael L. Curtin is a scholar working on Oncology, Cancer Research and Organic Chemistry, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Histone Deacetylase Inhibitors Research (10 papers) and Protein Degradation and Inhibitors (9 papers). The work is most often cited by research in Organic Chemistry (633 citations), Oncology (286 citations) and Molecular Biology (640 citations). Michael L. Curtin has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Keith B. Glaser, William H. Okamura, Steven K. Davidsen, Patrick A. Marcotte, Michael R. Michaelides, Robin R. Frey, Lori J. Pease, Robert B. Garland, H. Robin Heyman and Junling Li. Their work appears in journals such as New England Journal of Medicine, Journal of the American Chemical Society and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.